Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen
Publikationen
Ergebnisse pro Seite:  10



Schmidtmann, I; Blettner, M

How Do Cancer Registries in Europe Estimate Completeness of Registration

Method Inform Med. Bd. 48. 2009 S. 267-271


Clemen, CS; Fischer, D; Reimann, J et al.

How much mutant protein is needed to cause a protein aggregate myopathy in vivo? Lessons from an exceptional desminopathy.

Hum Mutat. Bd. 30. H. 3. 2009 S. E490-9




Faber, J; Krivtsov, AV; Stubbs, MC et al.

HOXA9 is required for survival in human MLL-rearranged acute leukemias.

Blood. Bd. 113. H. 11. 2009 S. 2375-85


Benachour, H; Zaiou, M; Herbeth, B et al.

Human formyl peptide receptor 1 (FPR1) c.32C>T SNP is associated with decreased soluble E-selectin levels.

Pharmacogenomics. Bd. 10. H. 6. 2009 S. 951-9


Adler, H.; Hermann, F.; Martin, H. et al.

Human IL-10 modulated dendtrituic cells migrate to secondary lymphoid tissues but do not affect lethal GvHD in a humanized mouse model

European Journal of Immunology. Bd. 39. H. 1. 2009 S. 364-364


Kubach, J; Becker, C; Michel, K et al.

Humanized mice: Effective models for preclinical testing of novel biologicalsagainst allergy and autoimmunity?

EXPERIMENTAL DERMATOLOGY. Bd. 18. H. 3. 2009 S. 294-294